AVTR

AVTR

USD

Avantor Inc. Common Stock

$12.870-0.330 (-2.500%)

Precio en Tiempo Real

Healthcare
Medical Instruments & Supplies
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$13.200

Máximo

$13.360

Mínimo

$12.725

Volumen

0.31M

Fundamentos de la Empresa

Capitalización de Mercado

8.8B

Industria

Medical Instruments & Supplies

País

United States

Estadísticas de Negociación

Volumen Promedio

10.33M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $12.195Actual $12.870Máximo $28

Noticias Relacionadas

PR Newswire

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

Ver más
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference
Analyst Upgrades

Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14

Goldman Sachs analyst Matthew Sykes downgrades Avantor from Buy to Neutral and lowers the price target from $23 to $14.

Ver más
Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14
Analyst Upgrades

RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20

RBC Capital analyst Conor McNamara maintains Avantor with a Outperform and lowers the price target from $24 to $20.

Ver más
RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20
Analyst Upgrades

Stifel Downgrades Avantor to Hold, Lowers Price Target to $14

Stifel analyst Daniel Arias downgrades Avantor from Buy to Hold and lowers the price target from $26 to $14.

Ver más
Stifel Downgrades Avantor to Hold, Lowers Price Target to $14
Analyst Upgrades

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

Morgan Stanley analyst Tejas Savant downgrades Avantor from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Ver más
Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15
Analyst Upgrades

Baird Maintains Outperform on Avantor, Lowers Price Target to $17

Baird analyst Catherine Schulte maintains Avantor with a Outperform and lowers the price target from $21 to $17.

Analyst Upgrades

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up.

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.